<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35266431</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>11</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>17</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1521-0464</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>29</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Drug delivery</Title>
          <ISOAbbreviation>Drug Deliv</ISOAbbreviation>
        </Journal>
        <ArticleTitle>D-optimal mixture design for optimization of topical dapsone niosomes: in vitro characterization and in vivo activity against <i>Cutibacterium acnes</i>.</ArticleTitle>
        <Pagination>
          <StartPage>821</StartPage>
          <EndPage>836</EndPage>
          <MedlinePgn>821-836</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/10717544.2022.2048131</ELocationID>
        <Abstract>
          <AbstractText>This study aimed to illustrate the use of D-optimal mixture design (DOMD) for optimization of an enhancer containing Dapsone niosomal formula for acne topical treatment. Mixture components (MixCs) studied were: Span 20, Cholesterol, and Cremophor RH. Different responses were measured. Optimized formula (OF) was selected to minimize particle size and maximize absolute zeta potential and entrapment efficiency. Optimized formula gel (OF-gel) was prepared and characterized. OF-gel in vivo skin penetration using confocal laser scanning microscopy and activity against <i>Cutibacterium acnes</i> in acne mouse model were studied. Based on DOMD results analysis, adequate models were derived. Piepel and contour plots were plotted accordingly to explain how alteration in MixCs L-pseudo values affected studied responses and regions for different responses' values. The OF had suitable predicted responses which were in good correlation with the actually measured ones. The OF-gel showed suitable characterization and in vivo skin penetration up to the dermis layer. In vivo acne mouse-model showed that OF-gel-treated group (OF-gel-T-gp) had significantly better recovery (healing) criteria than untreated (UT-gp) and Aknemycin<sup>®</sup>-treated (A-T-gp) groups. This was evident in significantly higher reduction of inflammation percent observed in OF-gel-T-gp than both UT-gp and A-T-gp. Better healing in OF-gel-T-gp compared with other groups was also verified by histopathological examination. Moreover, OF-gel-T-gp and A-T-gp bacterial loads were non-significantly different from each other but significantly lower than UT-gp. Thus, DOMD was an adequate statistical tool for optimization of an appropriate enhancer containing Dapsone niosomal formula that proved to be promising for topical treatment of acne.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Habib</LastName>
            <ForeName>Basant A</ForeName>
            <Initials>BA</Initials>
            <Identifier Source="ORCID">0000-0001-5083-3009</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, Egypt.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Abdeltawab</LastName>
            <ForeName>Nourtan F</ForeName>
            <Initials>NF</Initials>
            <Identifier Source="ORCID">0000-0002-1290-2197</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Microbiology and Immunology, Faculty of Pharmacy, Cairo University, Cairo, Egypt.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Salah Ad-Din</LastName>
            <ForeName>Ibtehal</ForeName>
            <Initials>I</Initials>
            <Identifier Source="ORCID">0000-0003-3937-8089</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, Egypt.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Drug Deliv</MedlineTA>
        <NlmUniqueID>9417471</NlmUniqueID>
        <ISSNLinking>1071-7544</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D008081">Liposomes</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>8W5C518302</RegistryNumber>
          <NameOfSubstance UI="D003622">Dapsone</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000152" MajorTopicYN="Y">Acne Vulgaris</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003622" MajorTopicYN="N">Dapsone</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008081" MajorTopicYN="Y">Liposomes</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010316" MajorTopicYN="N">Particle Size</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012867" MajorTopicYN="N">Skin</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012869" MajorTopicYN="N">Skin Absorption</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Box-Cox transformation</Keyword>
        <Keyword MajorTopicYN="N">Leverage</Keyword>
        <Keyword MajorTopicYN="N">Piepel’s plots</Keyword>
        <Keyword MajorTopicYN="N">animal model</Keyword>
        <Keyword MajorTopicYN="N">contour plots</Keyword>
        <Keyword MajorTopicYN="N">cutibacterium acnes</Keyword>
        <Keyword MajorTopicYN="N">variance inflation factor</Keyword>
      </KeywordList>
      <CoiStatement>The authors report no conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>10</Day>
          <Hour>8</Hour>
          <Minute>39</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>11</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35266431</ArticleId>
        <ArticleId IdType="pmc">PMC8920366</ArticleId>
        <ArticleId IdType="doi">10.1080/10717544.2022.2048131</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Abd-Elsalam WH, El-Zahaby SA, Al-Mahallawi AM. (2018). Formulation and in vivo assessment of terconazole-loaded polymeric mixed micelles enriched with Cremophor EL as dual functioning mediator for augmenting physical stability and skin delivery. Drug Deliv
25:484–92.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6058577</ArticleId>
            <ArticleId IdType="pubmed">29411650</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Abdelbary AA, Abd-Elsalam WH, Al-mahallawi AM. (2016). Fabrication of novel ultradeformable bilosomes for enhanced ocular delivery of terconazole: in vitro characterization, ex vivo permeation and in vivo safety assessment. Int J Pharm
513:688–96.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27717916</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Abdelbary G, El-Gendy N. (2008). Niosome-Encapsulated gentamicin for ophthalmic controlled delivery. AAPS PharmSciTech
9:740–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2977028</ArticleId>
            <ArticleId IdType="pubmed">18563578</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ahmed S, Kassem MA, Sayed S. (2020). Bilosomes as promising nanovesicular carriers for improved transdermal delivery: construction, in vitro optimization, ex vivo permeation and in vivo evaluation. Int J Nanomedicine
15:9783–98.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7733410</ArticleId>
            <ArticleId IdType="pubmed">33324052</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Allam A, Elsabahy M, El Badry M, Eleraky NE. (2021). Betaxolol-loaded niosomes integrated within pH-sensitive in situ forming gel for management of glaucoma . Int J Pharm
598:120380.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33609725</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alomrani AH, Al-Agamy MH, Badran MM. (2015). In vitro skin penetration and antimycotic activity of itraconazole loaded niosomes: various non-ionic surfactants. J Drug Deliv Sci Technol
28:37–45.</Citation>
        </Reference>
        <Reference>
          <Citation>An HJ, Lee WR, Kim KH, et al.  (2014). Inhibitory effects of bee venom on Propionibacterium acnes-induced inflammatory skin disease in an animal model. Int J Mol Med
34:1341–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25215662</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Armstrong NA.
2006. Pharmaceutical experimental design and interpretation. Florida: Taylor &amp; Francis Group: Informa Healthcare.</Citation>
        </Reference>
        <Reference>
          <Citation>Asasutjarit R, Lorenzen SI, Sirivichayakul S, et al.  (2007). Effect of solid lipid nanoparticles formulation compositions on their size, zeta potential and potential for in vitro pHIS-HIV-hugag transfection. Pharm Res
24:1098–107.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17385021</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Asthana GS, Sharma PK, Asthana A. (2016). In vitro and in vivo evaluation of niosomal formulation for controlled delivery of clarithromycin. Scientifica
2016:6492953.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4884864</ArticleId>
            <ArticleId IdType="pubmed">27293976</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Azzi L, El-Alfy M, Martel C, Labrie F. (2005). Gender differences in mouse skin morphology and specific effects of sex steroids and dehydroepiandrosterone. J Invest Dermatol
124:22–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15654949</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Badri W, Miladi K, Eddabra R, et al.  (2015). Elaboration of nanoparticles containing indomethacin: argan oil for transdermal local and cosmetic application. J Nanomater
2015:1–9.</Citation>
        </Reference>
        <Reference>
          <Citation>Balakrishnan P, Shanmugam S, Lee WS, et al.  (2009). Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery. Int J Pharm
377:1–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19394413</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bangham A, Standish M, Watkins J. (1965). Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol
13:238–52.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">5859039</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Budhiraja A, Dhingra G. (2015). Development and characterization of a novel antiacne niosomal gel of rosmarinic acid. Drug Deliv
22:723–30.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24786487</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cornell JA.
2002. Experiments with mixtures: designs, models, and the analysis of mixture data. 3rd ed. New York: John Wiley &amp; Sons, Inc.</Citation>
        </Reference>
        <Reference>
          <Citation>Draelos ZD, Carter E, Maloney JM, et al.  (2007). Two randomized studies demonstrate the efficacy and safety of dapsone gel, 5% for the treatment of acne vulgaris. J Am Acad Dermatol
56:439.e1–439.e10.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17208334</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>El-Nabarawi MA, Shamma RN, Farouk F, Nasralla SM. (2018). Dapsone-loaded invasomes as a potential treatment of acne: preparation, characterization, and in vivo skin deposition assay. AAPS PharmSciTech
19:2174–84.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29725903</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>El-Nabarawi MA, Shamma RN, Farouk F, Nasralla SM. (2020). Bilosomes as a novel carrier for the cutaneous delivery for dapsone as a potential treatment of acne: preparation, characterization and in vivo skin deposition assay. J Liposome Res
30:1–11.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31010357</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>El-Ridy MS, Yehia SA, Mohsen AM, et al.  (2017). Formulation of niosomal gel for enhanced transdermal lornoxicam delivery: in-vitro and in-vivo evaluation. Curr Drug Deliv
15:122–33.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28240177</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Elsheikh MA, Elnaggar YSR, Hamdy DA, Abdallah OY. (2018). Novel cremochylomicrons for improved oral bioavailability of the antineoplastic phytomedicine berberine chloride: optimization and pharmacokinetics. Int J Pharm
535:316–24.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29138046</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ephrem E, Greige-Gerges H, Fessi H, Charcosset C. (2014). Optimisation of rosemary oil encapsulation in polycaprolactone and scale-up of the process. J Microencapsul
31:746–53.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24963962</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fahmy AM, El-Setouhy DA, Habib BA, Tayel SA. (2019). Enhancement of transdermal delivery of haloperidol via spanlastic dispersions: entrapment efficiency vs. particle size. AAPS PharmSciTech
20:1–13.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30694404</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fahmy AM, El-Setouhy DA, Ibrahim AB, et al.  (2018). Penetration enhancer-containing spanlastics (PECSs) for transdermal delivery of haloperidol: in vitro characterization, ex vivo permeation and in vivo biodistribution studies. Drug Deliv
25.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6058714</ArticleId>
            <ArticleId IdType="pubmed">29219628</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Farid M, El-Setouhy DA, El-Nabarawi MA, El-Bayomi T. (2016). Particle engineering/different film approaches for earlier absorption of meloxicam. Drug Deliv
23:2309–17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25431841</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fetih G. (2016). Fluconazole-loaded niosomal gels as a topical ocular drug delivery system for corneal fungal infections. J Drug Deliv Sci Technol
35:8–15.</Citation>
        </Reference>
        <Reference>
          <Citation>Gonnissen Y, Gonçalves SIV, De Geest BG, et al.  (2008). Process design applied to optimise a directly compressible powder produced via a continuous manufacturing process. Eur J Pharm Biopharm
68:760–70.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17964129</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goyal G, Garg T, Malik B, et al.  (2015). Development and characterization of niosomal gel for topical delivery of benzoyl peroxide. Drug Deliv
22:1027–42.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24251352</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gugleva V, Titeva S, Rangelov S, Momekova D. (2019). Design and in vitro evaluation of doxycycline hyclate niosomes as a potential ocular delivery system. Int J Pharm
567:118431.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31207279</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Habib BA, Abd El-Samiae AS, El-Houssieny BM, Tag R. (2021). Formulation, characterization, optimization, and in-vivo performance of febuxostat self-nano-emulsifying system loaded sublingual films. Drug Deliv
28:1321–33.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8260042</ArticleId>
            <ArticleId IdType="pubmed">34176376</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Habib BA, AbouGhaly MHH. (2016). Combined mixture-process variable approach: a suitable statistical tool for nanovesicular systems optimization. Expert Opin Drug Deliv
13:1–12.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27020331</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Habib BA, Rehim RTAE, Nour SA. (2014). Feasibility of optimizing trimetazidine dihydrochloride release from controlled porosity osmotic pump tablets of directly compressed cores. J Adv Res
5:347–56.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4294720</ArticleId>
            <ArticleId IdType="pubmed">25685502</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Habib BA, Sayed S, Elsayed GM. (2018). Enhanced transdermal delivery of ondansetron using nanovesicular systems: fabrication, characterization, optimization and ex-vivo permeation study-Box-Cox transformation practical example. Eur J Pharm Sci
115:352–61.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29407555</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Habib BA, Tag R, Nour SA. (2008). Factorial design approach for optimization of a gel formulation for in vitro iontophoretic transdermal delivery of granisetron. Bull Fac Pharm
49:305–13.</Citation>
        </Reference>
        <Reference>
          <Citation>Khalil RM, El-Bary AA, Kassem MA, et al.  (2013). Influence of formulation parameters on the physicochemical properties of meloxicam-loaded solid lipid nanoparticles. Pharm J
12:63–72.</Citation>
        </Reference>
        <Reference>
          <Citation>Khazaeli P, Pardakhty A, Shoorabi H. (2007). Caffeine-loaded niosomes: characterization and in vitro release studies. Drug Deliv
14:447–52.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17994362</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Madheswaran T, Baskaran R, Yong CS, Yoo BK. (2014). Enhanced topical delivery of finasteride using glyceryl monooleate-based liquid crystalline nanoparticles stabilized by cremophor surfactants. AAPS PharmSciTech
15:44–51.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3909160</ArticleId>
            <ArticleId IdType="pubmed">24222268</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Magarkar A, Dhawan V, Kallinteri P, et al.  (2014). Cholesterol level affects surface charge of lipid membranes in saline solution. Sci Rep
4:5005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4028897</ArticleId>
            <ArticleId IdType="pubmed">24845659</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Manconi M, Sinico C, Valenti D, et al.  (2006). Niosomes as carriers for tretinoin. III. A study into the in vitro cutaneous delivery of vesicle-incorporated tretinoin. Int J Pharm
311:11–19.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16439071</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mason RL, Gunst RF, Hess JL. (2003). Statistical design and analysis of experiments with applications to engineering and science. 2nd ed. Hoboken, New Jersey: John Wiley &amp; Sons, Inc.</Citation>
        </Reference>
        <Reference>
          <Citation>Master AM, Rodriguez ME, Kenney ME, et al.  (2010). Delivery of the photosensitizer Pc 4 in PEG-PCL micelles for in vitro PDT studies. J Pharm Sci
99:2386–2398.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19967780</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mehnert W, Mäder K. (2001). Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev
47:165–196.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11311991</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mehrnia MA, Jafari SM, Makhmal-Zadeh BS, Maghsoudlou Y. (2016). Crocin loaded nano-emulsions: factors affecting emulsion properties in spontaneous emulsification. Int J Biol Macromol
84:261–267.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26708427</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mirshahpanah P, Maibach HI. (2007). Models in acnegenesis. Cutan Ocul Toxicol
26:195–202.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17687685</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mohanraj VJ, Chen Y. (2006). Nanoparticles – a review. Trop J Pharm Res
5:561–573.</Citation>
        </Reference>
        <Reference>
          <Citation>Montgomery DC.
2013. Design and analysis of experiments. 8th ed., New York, NY: John Wiley &amp; Sons, Inc.</Citation>
        </Reference>
        <Reference>
          <Citation>Murillo N, Raoult D. (2013). Skin microbiota: overview and role in the skin diseases acne vulgaris and rosacea. Future Microbiol
8:209–222.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23374126</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nageeb El-Helaly S, Habib BA, Abd El-Rahman MK. (2018). Resolution V fractional factorial design for screening of factors affecting weakly basic drugs liposomal systems. Eur J Pharm Sci
119:249–258.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29689287</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nakatsuji T, Liu Y-T, Huang C-P, et al.  (2008). Antibodies elicited by inactivated Propionibacterium acnes-based vaccines exert protective immunity and attenuate the IL-8 production in human sebocytes: relevance to therapy for acne vulgaris. J Invest Dermatol
128:2451–2457.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3070419</ArticleId>
            <ArticleId IdType="pubmed">18463682</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Omar MM, Hasan OA, El Sisi AM. (2019). Preparation and optimization of lidocaine transferosomal gel containing permeation enhancers: a promising approach for enhancement of skin permeation. Int J Nanomedicine
14:1551–1562.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6396669</ArticleId>
            <ArticleId IdType="pubmed">30880964</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ostertag F, Weiss J, McClements DJ. (2012). Low-energy formation of edible nanoemulsions: factors influencing droplet size produced by emulsion phase inversion. J. Colloid Interface Sci
388:95–102.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22981587</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pat MS, Wayne B. (2014). Handbook for experimenters. Version 09.01.03, Stat-Ease, Inc., Minnesota, USA.</Citation>
        </Reference>
        <Reference>
          <Citation>Pickert A, Raimer S. (2009). An evaluation of dapsone gel 5% in the treatment of acne vulgaris. Expert Opin Pharmacother
10:1515–1521.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19505219</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Platsidaki E, Dessinioti C. (2018). Recent advances in understanding Propionibacterium acnes (Cutibacterium acnes) in acne. F1000Res
7:1953–12.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6305227</ArticleId>
            <ArticleId IdType="pubmed">30613388</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ranpise NS, Korabu SS, Ghodake VN. (2014). Second generation lipid nanoparticles (NLC) as an oral drug carrier for delivery of lercanidipine hydrochloride. Colloids Surf B Biointerfaces
116:81–87.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24445002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ryu S, Han HM, Song PI, et al.  (2015). Suppression of propionibacterium acnes infection and the associated inflammatory response by the antimicrobial peptide P5 in mice. PLoS One
10:e0132619–18.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4510379</ArticleId>
            <ArticleId IdType="pubmed">26197393</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saberi AH, Fang Y, McClements DJ. (2013). Fabrication of vitamin E-enriched nanoemulsions: factors affecting particle size using spontaneous emulsification. J Colloid Interface Sci
391:95–102.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23116862</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Said M, Elsayed I, Aboelwafa A, Elshafeey A. (2018). A novel concept of overcoming the skin barrier using augmented liquid nanocrystals: Box-Behnken optimization, ex vivo and in vivo evaluation. Colloids Surf B Biointerfaces
170:258–265.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29935419</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Said M, Elsayed I, Aboelwafa AA, Elshafeey AH. (2017). Transdermal agomelatine microemulsion gel: Pyramidal screening, statistical optimization and in vivo bioavailability. Drug Deliv
24:1159–1169.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8241019</ArticleId>
            <ArticleId IdType="pubmed">28831842</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sago J, Hall RP. (2002). Dapsone. Dermatol Ther
15:340–351.</Citation>
        </Reference>
        <Reference>
          <Citation>Sayed S, Elsayed I, Ismail MM. (2018). Optimization of β-cyclodextrin consolidated micellar dispersion for promoting the transcorneal permeation of a practically insoluble drug. Int J Pharm
549:249–260.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30077759</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schneider-Rauber G, Argenta DF, Caon T. (2020). Emerging technologies to target drug delivery to the skin – the role of crystals and carrier-based systems in the case study of dapsone. Pharm Res
37:6–10.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33169237</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shaker S, Gardouh A, Ghorab M. (2017). Factors affecting liposomes particle size prepared by ethanol injection method. Res Pharm Sci
12:346–352.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5615864</ArticleId>
            <ArticleId IdType="pubmed">28974972</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shamma RN, Salah Ad-din I, Abdeltawab NF. (2019). Dapsone- gel as a novel platform for acne treatment: in vitro evaluation and In vivo performance and histopathological studies in acne infected mice. J Drug Deliv Sci Technol
54:101238.</Citation>
        </Reference>
        <Reference>
          <Citation>Shinde UA, Kanojiya SS. (2014). Serratiopeptidase niosomal gel with potential in topical delivery. J. Pharm
2014:1–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4590824</ArticleId>
            <ArticleId IdType="pubmed">26556195</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Taleb MH, Abdeltawab NF, Shamma RN, et al.  (2018). Origanum vulgare L. Essential oil as a potential anti-acne topical nanoemulsion—in vitro and in vivo study. Molecules
23:2164.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6225355</ArticleId>
            <ArticleId IdType="pubmed">30154336</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Voinovich D, Campisi B, Phan-Tan-Luu R.. 
2009. Experimental design for mixture studies. In: Brown S, Tauler R, Walczak B eds. Comprehensive chemometrics: chemical and biochemical data analysis. Amsterdam: Elsevier B.V. 391–452
pp.</Citation>
        </Reference>
        <Reference>
          <Citation>Yoshioka T, Sternberg B, Florence A. (1994). Preparation and properties of vesicles (niosomes) of sorbitan monoesters (Span 20,40,60 and 80) and a sorbitan triester (Span 85). Int J Pharm
105:1–6.</Citation>
        </Reference>
        <Reference>
          <Citation>Younes NF, Abdel-Halim SA, Elassasy AI. (2018). Corneal targeted sertaconazole nitrate loaded cubosomes: preparation, statistical optimization, in vitro characterization, ex vivo permeation and in vivo studies. Int J Pharm
553:386–397.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30393167</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang Y, Jing Q, Hu H, et al.  (2020). Sodium dodecyl sulfate improved stability and transdermal delivery of salidroside-encapsulated niosomes via effects on zeta potential. Int J Pharm
580:119183.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32112930</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
